AVITA Medical to Announce Third Quarter 2024 Financial Results
Avita Medical, Inc. (RCEL)
Company Research
Source: GlobeNewswire
VALENCIA, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that it will report its third quarter 2024 financial results after the close of the U.S. financial markets on Thursday, November 7, 2024. AVITA Medical will host a conference call and webcast that day at 1:30 p.m. Pacific Time (Friday, November 8, 2024, at 8:30 a.m. Australian Eastern Daylight Time) to discuss its financial results and recent business highlights. The live webcast will be accessible under the Events & Presentations section of the AVITA Medical website at ir.avitamedical.com. To participate by telephone, please register in advance to receive dial-in details and a personal PIN using this link. A replay of the webcast will be available shortly after the live event on the Investor Relations website. About AVITA Medical, Inc.AVIT
Show less
Read more
Impact Snapshot
Event Time:
RCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RCEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RCEL alerts
High impacting Avita Medical, Inc. news events
Weekly update
A roundup of the hottest topics
RCEL
News
- AVITA Medical, Inc. (NASDAQ: RCEL) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $21.00 price target on the stock.MarketBeat
- AVITA Medical, Inc. (NASDAQ: RCEL) is now covered by analysts at D. Boral Capital. They set a "buy" rating and a $25.00 price target on the stock.MarketBeat
- AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds [Yahoo! Finance]Yahoo! Finance
- AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller WoundsGlobeNewswire
- AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market [Yahoo! Finance]Yahoo! Finance
RCEL
Earnings
- 11/7/24 - Miss
RCEL
Sec Filings
- 12/5/24 - Form 4
- 11/7/24 - Form 10-Q
- 11/7/24 - Form 8-K
- RCEL's page on the SEC website